MedPath

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

Conditions
Non-Small Cell Lung Carcinoma
Venous Thromboembolism
Registration Number
NCT00192829
Lead Sponsor
Rambam Health Care Campus
Brief Summary

The association between cancer and thrombosis is well known and the occurrence of thrombotic complications is commonly associated with poor prognosis. The aim os this study is to determine the possible value of hypercoagulable parameters as prognostic parameters in advanced non-small cell lung carcinoma (NSCLC).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Histologically or cytologically confirmed diagnosis of NSCLC.
  • normal serum bilirubin
  • informed concent to participate in the study
Exclusion Criteria
  • anticoagulant therapy
  • infectious disease

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Hematology Laboratory

🇮🇱

Haifa, Israel

Oncology Institution, Rambam Health Campus

🇮🇱

Haifa, Israel

© Copyright 2025. All Rights Reserved by MedPath